Scarica l'app Stockscreener
27.15
1.76%
0.47
Dopo l'orario di chiusura:
27.20
0.05
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACAD Giù?
Forum
Previsione
Acadia Pharmaceuticals Inc Borsa (ACAD) Ultime notizie
Hohimer Wealth Management LLC Decreases Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
TFG Asset Management GP Ltd Has $3.48 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Eventide Asset Management LLC Trims Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Birchview Capital LP Sells 75,600 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
FDA approves powder formulation of trofinetide for Rett syndrome - Contemporary Pediatrics
FDA Approves New Formulation for Acadia Pharmaceuticals' (ACAD) Rett Syndrome Treatment - GuruFocus
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome - The Joplin Globe
STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome - Business Wire
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes $928,000 Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Acadia Pharmaceuticals stock price target raised by Stifel to $25 from $24 - Investing.com Canada
Should ACADIA’s Earnings Beat and Conference Highlights Require Action From ACADIA Pharmaceuticals (ACAD) Investors? - Sahm
Stifel Nicolaus Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price - MarketBeat
Stifel Maintains Hold Rating and Raises Price Target for ACAD to $25.00 | ACAD Stock News - GuruFocus
What drives ACADIA Pharmaceuticals Inc stock priceReal Estate Investment Trusts & Affordable Market Investment - earlytimes.in
Norges Bank Invests $31.68 Million in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals Inc. $ACAD Shares Bought by First Trust Advisors LP - MarketBeat
(ACAD) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Marshall Wace LLP Purchases 1,639,315 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Swing Trade: Can ACADIA Pharmaceuticals Inc stock maintain growth trajectoryJuly 2025 Short Interest & Verified Stock Trade Ideas - moha.gov.vn
Assessing ACADIA Pharmaceuticals Valuation After Strong 2024 Share Price Rally - Yahoo Finance
MACD Signal: Is ACADIA Pharmaceuticals Inc stock a buy in volatile marketsJuly 2025 Market Mood & Community Consensus Trade Signals - moha.gov.vn
ACADIA Pharmaceuticals (ACAD) Is Up 9.6% After Earnings Beat And NUPLAZID Patent Extension News - Yahoo Finance
Assessing Acadia Pharmaceuticals (ACAD) Valuation After Strong Q3 Results and Extended NUPLAZID Patent Protection - Yahoo Finance
State Board of Administration of Florida Retirement System Increases Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals (ACAD) Receives a Buy from UBS - The Globe and Mail
ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 12-Month HighShould You Buy? - MarketBeat
Why Is Acadia (ACAD) Up 22.6% Since Last Earnings Report? - sharewise.com
Is ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Recent Stock Performance Tethered To Its Strong Fundamentals? - 富途牛牛
Stonepine Capital Management LLC Has $4.85 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Acadia Pharmaceuticals stock hits 52-week high at 26.65 USD By Investing.com - Investing.com Nigeria
Fisher Asset Management LLC Sells 44,710 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Edgestream Partners L.P. Sells 47,964 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Is ACADIA Pharmaceuticals Inc. stock safe for conservative investorsQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Acadia Pharmaceuticals (ACAD): Reassessing Valuation After Strong Q3 Earnings Beat and Higher Analyst Price Targets - Sahm
Buy Acadia Pharmaceuticals For Daybue/Nuplazid Stability And Pipeline Optionality (ACAD) - Seeking Alpha
Acadia Pharmaceuticals stock hits 52-week high at 26.65 USD - Investing.com India
UBS Adjusts ACADIA Pharmaceuticals Price Target to $35 From $39, Maintains Buy Rating - marketscreener.com
Acadia Pharmaceuticals stock price target lowered to $35 at UBS By Investing.com - Investing.com UK
Can ACADIA Pharmaceuticals Inc. stock maintain operating margins2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts - Yahoo Finance
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - The Motley Fool
Acadia to pivot to Alzheimer’s psychosis pipeline, accd to Wall Street analysts - Yahoo Finance UK
Capital Fund Management S.A. Reduces Stock Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
How ACADIA Pharmaceuticals Inc. stock benefits from tech adoption2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
ACADIA Pharmaceuticals (ACAD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Mizuho Maintains 'Neutral' Rating on ACAD, Raises Price Target t - GuruFocus
Acadia Pharmaceuticals stock price target raised by Mizuho to $29 - Investing.com Canada
ACADIA Pharmaceuticals Inc Stock Analysis and ForecastCurrency Fluctuation Impact & Free Trading Psychology Sessions - earlytimes.in
F m Investments LLC Lowers Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Ensign Peak Advisors Inc Cuts Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
American Century Companies Inc. Sells 65,361 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Is ACADIA Pharmaceuticals Inc a good long term investmentEvening Star Patterns & High Profit Growth Stocks - earlytimes.in
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock - MSN
Summit Global Investments Reduces Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Prudential Financial Inc. Raises Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
(ACAD) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Stocks Flashing Renewed Technical Strength: ACADIA Pharmaceuticals - Investor's Business Daily
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):